NxStage Medical, Inc. NXTM recently announced the regulatory approval of its System One platform by the FDA for solo home hemodialysis treatment. The company has also announced that it will provide ...

LAWRENCE, Mass., Oct. 5, 2012 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today commented on a review article published on October 4 ...

NxStage Medical, Inc. NXTM recently announced the receipt of CE mark for its NxGen Hemodialysis System, an innovative device with easier user interface and integrated blood pressure monitor system for ...

Home dialysis specialist NxStage Medical (NXTM +0.00%) has made a huge change in how patients get the treatment they need, offering an alternative to the outpatient services that Fresenius Medical ...

Please provide your email address to receive an email when new articles are posted on . NxStage Medical Inc.’s next generation System One hemodialysis system has received the CE mark in Europe. The ...

Please provide your email address to receive an email when new articles are posted on . The U.S. Food and Drug Administration has cleared NxStage Medical Inc.'s System One to perform home nocturnal ...

LAWRENCE, Mass. (AP) -- Medical device maker NxStage Medical Inc. said Tuesday its first-quarter loss narrowed as revenue climbed on growing adoption of its NxStage System One home kidney dialysis ...

NxStage Medical, Inc.NXTM recently announced the receipt of CE mark for its NxGen Hemodialysis System, an innovative device with easier user interface and integrated blood pressure monitor system for ...